Medicare Enrolled
Dr. Nagaprasad Nagajothi, M.D.
Hematology & Oncology · Massillon, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nagajothi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nagajothi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nagajothi
Dr. Nagaprasad Nagajothi is a hematology & oncology specialist in Massillon, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nagajothi performed 176,925 Medicare services across 5,773 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nagajothi received a total of $25,175 from 98 pharmaceutical and/or device companies across 981 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nagajothi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in OH
$25,175 industry payments
Medicare Practice Summary
Medicare Utilization ↗176,925
Medicare services
Top 1% in OH for hematology & oncology
5,773
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~8,846 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
96,000 | $1 | $3 |
| Denosumab injection (Prolia/Xgeva) | 18,360 | $18 | $37 |
| Pembrolizumab injection (Keytruda) | 14,400 | $43 | $102 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
10,437 | $0 | $1 |
| Injection, granisetron, extended-release, 0.1 mg | 9,200 | $5 | $10 |
| Anti-nausea injection (aprepitant) | 7,540 | $1 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,694 | $8 | $19 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,567 | $8 | $15 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,170 | $6 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,150 | $0 | $1 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,258 | $10 | $33 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,131 | $92 | $173 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
588 | $13 | $25 |
| Iron level test | 560 | $6 | $23 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
555 | $9 | $37 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
552 | $11 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
536 | $58 | $133 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
452 | $97 | $207 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
449 | $21 | $51 |
| Anti-nausea injection (Aloxi/palonosetron) | 440 | $1 | $3 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
382 | $6 | $19 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
288 | $47 | $103 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
262 | $0 | $1 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
256 | $2 | $19 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
251 | $1 | $4 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
242 | $12 | $39 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
234 | $10 | $29 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
204 | $29 | $51 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
198 | $15 | $26 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
181 | $7 | $28 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
165 | $15 | $40 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
157 | $1 | $5 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
154 | $21 | $55 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
151 | $54 | $105 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
143 | $16 | $47 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
119 | $7 | $19 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
116 | $48 | $105 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
116 | $2 | $5 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
112 | $60 | $137 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
111 | $24 | $74 |
| New patient office visit, complex (60-74 min) | 109 | $152 | $271 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
106 | $4 | $23 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
102 | $1 | $6 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
89 | $14 | $26 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
84 | $7 | $20 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
79 | $137 | $227 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
78 | $17 | $48 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
65 | $136 | $231 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
62 | $69 | $70 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
53 | $28 | $75 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
50 | $8 | $15 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
42 | $64 | $138 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
37 | $15 | $31 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $42 | $79 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
29 | $4 | $6 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
11 | $76 | $139 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $29 | $43 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
55.3% high complexity
37.7% medium
7.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,175
Total received (2018-2024)
Avg $3,596/year across 7 years
Top 17% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
98
Companies
981
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,456 (73.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,434 (25.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$285 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,380
2023
$3,346
2022
$2,792
2021
$2,103
2020
$1,720
2019
$9,545
2018
$2,289
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$269
PFIZER INC.
$221
Eisai Inc.
$205
ABBVIE INC.
$189
Merck Sharp & Dohme LLC
$185
AstraZeneca Pharmaceuticals LP
$145
Janssen Biotech, Inc.
$132
TAIHO ONCOLOGY, INC.
$121
E.R. Squibb & Sons, L.L.C.
$120
Celgene Corporation
$107
EMD Serono, Inc.
$99
Takeda Pharmaceuticals U.S.A., Inc.
$99
Daiichi Sankyo Inc.
$90
GENZYME CORPORATION
$86
Astellas Pharma US Inc
$76
Stemline Therapeutics Inc.
$67
Genmab U.S., Inc.
$62
Mirati Therapeutics, Inc.
$52
Karyopharm Therapeutics Inc.
$49
Aveo Pharmaceuticals, Inc.
$48
GlaxoSmithKline, LLC.
$48
Exelixis Inc.
$46
Pharmacosmos Therapeutics Inc.
$43
Incyte Corporation
$43
Apellis Pharmaceuticals, Inc.
$42
Lilly USA, LLC
$41
Bayer Healthcare Pharmaceuticals Inc.
$40
JAZZ PHARMACEUTICALS INC.
$39
Tempus AI, Inc
$38
Deciphera Pharmaceuticals Inc.
$36
Rigel Pharmaceuticals, Inc.
$34
Regeneron Healthcare Solutions, Inc.
$34
Ipsen Biopharmaceuticals, Inc
$34
Sumitomo Pharma America, Inc.
$32
PUMA BIOTECHNOLOGY, INC.
$31
TerSera Therapeutics LLC
$28
Genentech USA, Inc.
$28
Coherus Biosciences Inc.
$26
MorphoSys, US Inc.
$22
ShockWave Medical, Inc
$22
ADC Therapeutics America, Inc.
$21
Biocon Biologics Inc
$21
SOBI, INC
$20
Alexion Pharmaceuticals, Inc.
$20
Iovance Biotherapeutics, Inc.
$20
Octapharma USA, Inc.
$19
Spectrum Pharmaceuticals Inc.
$18
Kyowa Kirin, Inc.
$18
SERVIER PHARMACEUTICALS LLC
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Novocure Inc.
$16
Teva Pharmaceuticals USA, Inc.
$15
Kite Pharma, Inc.
$15
ARRAY BIOPHARMA INC
$14
Top 3 companies account for 20.6% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$6,736
Tosoh Bioscience, Inc.
$1,674
Novartis Pharmaceuticals Corporation
$1,492
E.R. Squibb & Sons, L.L.C.
$1,308
Celgene Corporation
$760
Janssen Biotech, Inc.
$668
Amgen Inc.
$604
AstraZeneca Pharmaceuticals LP
$557
PFIZER INC.
$534
Merck Sharp & Dohme LLC
$501
Astellas Pharma US Inc
$451
Genentech USA, Inc.
$431
Eisai Inc.
$421
Incyte Corporation
$421
Merck Sharp & Dohme Corporation
$405
Pharmacyclics LLC, An AbbVie Company
$401
Daiichi Sankyo Inc.
$371
Lilly USA, LLC
$355
Takeda Pharmaceuticals U.S.A., Inc.
$301
Seagen Inc.
$275
EMD Serono, Inc.
$243
ABBVIE INC.
$229
Ipsen Biopharmaceuticals, Inc
$211
Boehringer Ingelheim Pharmaceuticals, Inc.
$210
EUSA Pharma (US) LLC
$201
GlaxoSmithKline, LLC.
$198
Agios Pharmaceuticals, Inc.
$193
Exelixis Inc.
$190
Bayer HealthCare Pharmaceuticals Inc.
$184
Pharmacosmos Therapeutics Inc.
$183
Mirati Therapeutics, Inc.
$181
Pharmacyclics LLC, an AbbVie Company
$163
ARRAY BIOPHARMA INC
$161
Genmab U.S., Inc.
$154
Karyopharm Therapeutics Inc.
$144
Epizyme, Inc.,
$138
Rigel Pharmaceuticals, Inc.
$134
Stemline Therapeutics Inc.
$132
TESARO, Inc.
$129
Regeneron Healthcare Solutions, Inc.
$122
AMAG Pharmaceuticals, Inc.
$122
TAIHO ONCOLOGY, INC.
$121
EISAI INC.
$120
Myriad Genetic Laboratories, Inc.
$105
SOBI, INC
$103
AVEO Pharmaceuticals, Inc.
$100
JAZZ PHARMACEUTICALS INC.
$97
Janssen Pharmaceuticals, Inc
$93
Dendreon Pharmaceuticals LLC
$92
Jazz Pharmaceuticals Inc.
$91
Myovant Sciences Inc.
$89
MorphoSys, US Inc.
$86
Bayer Healthcare Pharmaceuticals Inc.
$86
BeiGene USA, Inc.
$83
Puma Biotechnology, Inc.
$82
Taiho Oncology, Inc.
$72
Apellis Pharmaceuticals, Inc.
$71
Acceleron Pharma, Inc.
$69
Kite Pharma, Inc.
$66
Aveo Pharmaceuticals, Inc.
$60
G1 Therapeutics, Inc.
$58
Sumitomo Pharma America, Inc.
$56
Coherus Biosciences Inc.
$54
Teva Pharmaceuticals USA, Inc.
$54
Gilead Sciences, Inc.
$54
PharmaEssentia USA Corporation
$52
Deciphera Pharmaceuticals Inc.
$51
PUMA BIOTECHNOLOGY, INC.
$45
Mylan Institutional Inc.
$43
Blueprint Medicines Corporation
$42
Sobi, Inc
$41
Secura Bio, Inc.
$40
Tempus AI, Inc
$38
Organon LLC
$37
Clovis Oncology, Inc.
$36
Heron Therapeutics, Inc.
$35
Spectrum Pharmaceuticals Inc.
$32
Alexion Pharmaceuticals, Inc.
$32
SERVIER PHARMACEUTICALS LLC
$32
NOVARTIS PHARMACEUTICALS CORPORATION
$31
TerSera Therapeutics LLC
$28
Kyowa Kirin, Inc.
$28
AbbVie, Inc.
$27
ShockWave Medical, Inc
$22
ADC Therapeutics America, Inc.
$21
Biocon Biologics Inc
$21
Iovance Biotherapeutics, Inc.
$20
Octapharma USA, Inc.
$19
Adaptive Biotechnologies Corporation
$19
CTI BioPharma Corp.
$17
Otsuka America Pharmaceutical, Inc.
$16
Sirtex Medical Inc
$16
Novocure Inc.
$16
AbbVie Inc.
$15
Lexicon Pharmaceuticals, Inc.
$15
Sun Pharmaceutical Industries Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$12
Servier Pharmaceuticals LLC
$11
Top 3 companies account for 39.3% of all-time payments
Associated products mentioned in payments ›
27.29 · ABECMA · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · Avastin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FABRAZYME · FABRY-DISEASE · FARESTON · FARYDAK · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idhifa · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MOZOBIL · MVASI · MYRISK · Monoferric · NERLYNX · NEXPLANON · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · ST AIA-PACK · SUSTOL · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Stivarga · Sustol · Sylvant · TAFINLAR · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · Tibsovo · Tivdak · Truxima · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
30
Per 100K population
8.0
County median income
$65,740
Nearest hospital
MERCY MEDICAL CENTER
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nagajothi is a mixed practice specialist, with above-average Medicare volume (top 1% in OH), with low-engagement industry engagement in the top 17% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nagajothi experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Nagajothi performed 96,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nagajothi receive payments from pharmaceutical companies?
Yes. Dr. Nagajothi received a total of $25,175 from 98 companies across 981 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nagajothi's costs compare to other hematology & oncology specialists in Massillon?
Dr. Nagajothi's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nagajothi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Massillon
Browse hematology & oncology specialists in Massillon ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Tosoh Bioscience, Inc. Payments to Doctors
See all physicians who received payments from Tosoh Bioscience, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology